Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Prime Fungi is a life sciences company specializing in the development and production of high-potency medicinal mushroom extracts. The company utilizes advanced dual-extraction techniques to maximize the bioavailability of bioactive compounds such as beta-glucans, hericenones, and cordycepin. Their product portfolio includes extracts from Lion's Mane, Cordyceps, Reishi, and Turkey Tail, targeting cognitive enhancement, immune system modulation, and metabolic health. Prime Fungi focuses on rigorous quality control and standardized concentrations to provide therapeutic-grade fungal supplements for the consumer health market. The company distinguishes itself by using 100% fruiting bodies in its formulations, avoiding the fillers commonly found in mycelium-on-grain products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Prime Fungi.